BOLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Boundless Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.31−0.03 (-1.28%)
Close on Oct 19, 2026
- Market cap
- $51.86M
- P/E (TTM)
- –
- Dividend yield
- –
Boundless Bio statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Boundless Bio | Industry median |
|---|---|---|
| Market Cap | $52.55M | $166.30M |
| Enterprise Value | -$20.05M | $88.19M |
| PB Ratio | 0.80 | 2.03 |
| P/TBV Ratio | 0.80 | 2.29 |
Income (trailing twelve months)
| Measure | Boundless Bio | Industry median |
|---|---|---|
| Operating Income | -$68.01M | -$21.40M |
| Net Income | -$64.01M | -$22.46M |
| EBITDA | -$65.82M | -$16.91M |
| EPS (Diluted) | -$2.86 | -$0.83 |
Returns
| Measure | Boundless Bio | Industry median |
|---|---|---|
| Return on Equity (ROE) | -67.9% | -53.2% |
| Return on Assets (ROA) | -50.6% | -40.9% |
| Return on Capital Employed (ROCE) | -103.1% | -38.1% |
Balance sheet
| Measure | Boundless Bio | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $72.60M | $61.43M |
| Net Cash (Debt) | $72.60M | $15.35M |
| Net Cash Per Share | $3.19 | $0.66 |
| Equity (Book Value) | $65.98M | $49.09M |
| Book Value Per Share | $2.90 | $1.37 |
| Tangible Book Value | $65.98M | $23.52M |
| Working Capital | $65.88M | $76.81M |
Financial position
| Measure | Boundless Bio | Industry median |
|---|---|---|
| Current Ratio | 9.48 | 3.34 |
| Quick Ratio | 9.35 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Boundless Bio | Industry median |
|---|---|---|
| Operating Cash Flow | -$56.25M | -$12.35M |
| Capital Expenditures | -$485.00K | -$1.08M |
| Free Cash Flow | -$56.73M | -$20.22M |
| FCF Per Share | -$2.49 | -$0.42 |
Efficiency
| Measure | Boundless Bio | Industry median |
|---|---|---|
| Profits Per Employee | -$2.29M | -$703.34K |
| Employee Count | 28 | 74 |
Dividends and yields
| Measure | Boundless Bio | Industry median |
|---|---|---|
| Earnings Yield | -121.8% | -23.3% |
| FCF Yield | -108.0% | -8.72% |
Shares
| Measure | Boundless Bio | Industry median |
|---|---|---|
| Shares Outstanding | 22,748,000 | 58,127,000 |
| Shares Change (YoY) | 0.46% | 10.9% |
| Shares Change (QoQ) | 0.30% | 0.54% |
| Float | 14,408,100 | 49,136,700 |
| Shares Held by Insiders | 36.7% | 11.6% |
| Shares Held by Institutions | 67.3% | 59.4% |
Scores
| Measure | Boundless Bio | Industry median |
|---|---|---|
| Altman Z-Score | -3.55 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Boundless Bio's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.